Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
07/23/10 | Initial statement of beneficial ownership of securities | 3 | |||
07/12/10 | Statement of changes in beneficial ownership of securities | 1 | |||
07/12/10 | Statement of changes in beneficial ownership of securities | 2 | |||
04/26/10 | Statement of changes in beneficial ownership of securities | 2 | |||
02/17/10 | Statement of changes in beneficial ownership of securities | 1 | |||
02/17/10 | Statement of changes in beneficial ownership of securities | 2 | |||
02/12/10 | Annual statement of changes in beneficial ownership of securities | 1 | |||
01/21/10 | Statement of changes in beneficial ownership of securities | 1 | |||
01/21/10 | Statement of changes in beneficial ownership of securities | 2 | |||
10/29/09 | Initial statement of beneficial ownership of securities | 2 |